Hostname: page-component-cb9f654ff-9b74x Total loading time: 0 Render date: 2025-09-09T07:23:32.665Z Has data issue: false hasContentIssue false
  • English
  • Français

Status epilepticus, electroconvulsive therapy and malignant melanoma

Published online by Cambridge University Press:  13 June 2014

Kenneth R Kaufman  and
Aviva Olsavsky
Kenneth R Kaufman*
Affiliation:
Departments of Psychiatry, Neurology and Anaesthesiology, UMDNJ-Robert Wood Johnson Medical School, 125 Paterson Street Suite #2200, New Brunswick, NJ 08901, USA
Aviva Olsavsky
Affiliation:
Department of Neurology, Neurological Institute, Columbia University, 710 W 168th Street, New York, NY 10032, USA
*
*Correspondence E-mail: kaufmakr@umdnj.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

Status epilepticus (SE), both convulsive and nonconvulsive, is a rare adverse effect of electroconvulsive therapy (ECT). This case report describes SE post-ECT associated with central nervous system (CNS) metastatic melanoma and reviews pertinent literature. The authors recommend that when CNS pathology is suspected, pre-ECT neurology consultation, neuroimaging, and EEG all may be indicated. This is especially important for patients with histories of primary cancers, such as melanoma, that metastasise to the brain.

Keywords

ECTStatus epilepticusMelanomaCNS pathologyEEGNeuroimagingCTMRISeizure DurationDepression

Information

Type
Case Reports
Information
Irish Journal of Psychological Medicine , Volume 26 , Issue 2 , June 2009 , pp. 87 - 89
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1.American Psychiatric Association Committee on Electroconvulsive Therapy: The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging. A task force report of the American Psychiatric Association. 2nd Ed. Washington, DC: American Psychiatric Association, 2001.Google Scholar
2.Weiner, RD, Krystal, AD. The present use of electroconvulsive therapy. Annu Rev Med 1994;45:273–281.CrossRefGoogle ScholarPubMed
3.Grogan, R, Wagner, DR, Sullivan, T, Labar, D. Generalized nonconvulsive status epilepticus after electroconvulsive therapy. Convulsive Therapy 1995; 11: 51–56.Google ScholarPubMed
4.Weiner, RD, Volow, MR, Gianturco, DT, Cavenar, JO Jr. Seizures terminable and interminable with ECT. Am J Psychiatry 1980; 137: 1416–1418.Google ScholarPubMed
5.Weiner, RD. ECT-induced status epilepticus and further ECT: a case report. Am J Psychiatry 1981; 138(9): 1237–1238.Google ScholarPubMed
6.Scott, Al, Riddle, W. Status epilepticus after electroconvulsive therapy. Br J Psychiatry 1989; 155: 119–121.CrossRefGoogle ScholarPubMed
7.Povlsen, UJ, Wildschiodtz, G, Hogenhaven, H, Bolwig, TG. Nonconvulsive status epilepticus after electroconvulsive therapy. J ECT 2003; 19(3): 164–169.CrossRefGoogle ScholarPubMed
8.Kaufman, KR, Finstead, B, Kaufman, ER. Electroencephalography and electroconvulsive therapy. Electroencephalogr Clin Neurophysiol 1985; 61(3): S178.CrossRefGoogle Scholar
9.Kaufman, KR, Finstead, BA, Kaufman, ER. Status epilepticus following electroconvulsive therapy. Mt Sinai J Med 1986; 53(2): 119–122.Google ScholarPubMed
10.Peters, SG, Wochos, DN, Peterson, GC. Status epilepticus as a complication of concurrent electroconvulsive and theophylline therapy. Mayo Clin Proc 1984; 59(8):568–570.CrossRefGoogle ScholarPubMed
11.Coffey, CE, Figiel, GS, Weiner, RD, Saunders, WB. Caffeine augmentation of ECT. Am J Psychiatry 1990; 147(5): 579–585.Google ScholarPubMed
12.Kaufman, KR, Sachdeo, RC. Caffeinated beverages and decreased seizure control. Seizure 2003; 12(7): 519–521.CrossRefGoogle ScholarPubMed
13.American Psychiatric Association; Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association, 1994.Google Scholar
14.Treiman, DM, Meyers, PD, Walton, NYet al.A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 1998; 339(12): 792–798.CrossRefGoogle ScholarPubMed
15.Lowenstein, DH, Bleck, T, Macdonald, RL. It's time to revise the definition of status epilepticus. Epilepsia 1999; 40(1): 120–122.CrossRefGoogle ScholarPubMed
16.Jenssen, S, Gracely, EJ, Sperling, MR. How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit. Epilepsia 2006; 47(9): 1499–1503.CrossRefGoogle Scholar
17.Greco, Crasto S, Soffietti, R, Bradac, GB, Boldorini, R. Primitive cerebral melanoma: case report and review of the literature. Surg Neurol 2001; 55: 163–168.CrossRefGoogle Scholar
18.Freudenstein, D, Wagner, A, Bornemann, A, Ernemann, U, Bauer, T, Duffner, F. Primary melanocytic lesions of the CNS: report of five cases. Zentralbl Neurochir 2004; 65: 146–153.Google ScholarPubMed
19.Ferraresi, V, Ciccarese, M, Zeuli, M, Cognetti, F. Central nervous system as exclusive site of disease in patients with melanoma: treatment and clinical outcome of two cases. Melanoma Res 2005; 15(5): 467–469.CrossRefGoogle ScholarPubMed
20.Fife, KM, Colman, MH, Stevens, GNet al.Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 2004; 22(7): 1293–1300.CrossRefGoogle ScholarPubMed
21.Byrne, TN, Cascino, TL, Posner, JB. Brain metastasis from melanoma. J Neurooncol 1983; 1(4): 313–317.CrossRefGoogle ScholarPubMed
22.Oberndorfer, S, Schmal, T, Lahrmann, H, Urbanits, S, Lindner, K, Grisold, W. The frequency of seizures in patients with primary brain tumours or cerebral metastases. An evaluation from the Ludwig Blotzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna. Wien Klin Wochenschr 2002; 114(21-22): 911–916.Google ScholarPubMed
23.Herman, ST. Epilepsy after brain insult: Targeting epileptogenesis. Neurology 2002; 59(9) Supplement 5: S21–S26.CrossRefGoogle ScholarPubMed
24.Blitshteyn, S, Jaeckle, KA. Nonconvulsive status epilepticus in metastatic CNS disease. Neurology 2006; 66(8): 1261–1263.CrossRefGoogle ScholarPubMed
25.Madhusoodanan, S, Danan, D, Brenner, R, Bogunovic, O. Brain tumour and psychiatric manifestations: a case report and brief review. Ann Clin Psychiatry 2004; 16(2): 111–113.CrossRefGoogle ScholarPubMed
26.Rabheru, K. The use of electroconvulsive therapy in special patient populations. Can J Psychiatry 2002; 46(8): 710–719.CrossRefGoogle Scholar
27.Miyata, H, Kubato, F, Shibata, N, Kifune, A. Non-convulsive status epilepticus induced by antidepressants. Seizure 1997; 6(5): 405–407.CrossRefGoogle ScholarPubMed
28.Rowan, AJ, Rudolf, NDM, Scott, DF. EEG prediction of brain metastases. J Neurol Neurosurg Psychiatry 1974; 37: 888–893.CrossRefGoogle ScholarPubMed
29.Amer, MH, Al-Sarraf, M, Baker, LH, Vaitkevicius, VK. Malignant melanoma and central nervous system metastases. Incidence, diagnosis, treatment and survival. Cancer 1978; 42(2): 660–668.3.0.CO;2-E>CrossRefGoogle ScholarPubMed
30.Walker, R, Lieberman, AN, Pinto, Ret al.Transient neurologic disturbances, brain tumours, and normal computed tomography scans. Cancer 1983; 52(7): 1502–1506.3.0.CO;2-G>CrossRefGoogle ScholarPubMed
31.Hormigo, A, Liberato, B, Lis, E, DeAngelis, LM. Nonconvulsive status epilepticus in patients with cancer. Arch Neurol 2004; 61 (3): 363–365.CrossRefGoogle ScholarPubMed
32.Binnie, CD, Prior, PF. Electroencephalography. J Neurol Neurosurg Psychiatry 1994; 57(11): 1308–1319.CrossRefGoogle ScholarPubMed
33.Atlas, SW, Grossman, Rl, Gomori, JMet al.MR imaging of intracranial metastatic melanoma. J Comput Assist Tomogr 1987; 11 (4): 577–582.CrossRefGoogle ScholarPubMed
34.Reider-Groswasser, I, Merimsky, O, Karminsky, N, Chaitchik, S. Computer tomography features of cerebral spread of malignant melanoma. Am J Clin Oncol 1996; 19(1): 49–53.CrossRefGoogle ScholarPubMed
35.Soffietti, R, Ruda, R, Mutani, R. Management of brain metastases. J Neurol 2002; 249(10): 1357–1369.CrossRefGoogle ScholarPubMed
36.Gaviani, P, Mullins, ME, Braga, TAet al.Improved detection of metastatic melanomaby T2-weighted imaging. AJNR Am J Neuroradiol 2006; 27: 605–608.Google Scholar
37.Kakeda, S, Korogi, Y, Hiai, Yet al.Detection of brain metastasis at 3T: comparison among SE, IR-FSE, and 3D-GRE sequences. Eur Radiol 2007; 17(9): 2345–2351.CrossRefGoogle ScholarPubMed
38.Furutani, K, Harada, M, Mawlan, M, Nishitani, H. Difference in enhancement between spin echo and 3-dimensional fast spoiled gradient recalled acquisition in steady state magnetic resonance imaging of brain metastasis at 3-T magnetic resonance imaging. J Comput Assist Tomogr 2008; 32(2): 313–319.CrossRefGoogle ScholarPubMed
39.Baker, LC, Atlas, SW. Relationship between HMO market share and the diffusion and use of advanced MRI technologies. J Am Coll Radiol 2004; 1 (7): 478–487.CrossRefGoogle ScholarPubMed
40.Blachar, A, Tal, S, Mandel, Aet al.Preauthorization of CT and MRI examinations: assessment of a managed care preauthorization programbased on the ACR Appropriateness Criteria and the Royal College of Radiology guidelines. J Am Coll Radiol 2006; 3(11): 851–859.CrossRefGoogle Scholar
41.Banta, HD, Battista, RN, Gelband, H, Jonsson, E, Eds. Health Care Technology and Its Assessment in Eight Countries, washington, DC: United States Congress, 1995.Google Scholar
42.Lavayssiere, R, Cabee, AE. MRI in France: the French paradox. J Magn Reson Imaging 2001; 13(4); 528–533.CrossRefGoogle ScholarPubMed
43.Rao, VM, Parker, L, Levin, DC, Sunshine, J, Bushee, G. Use trends and geographic variation in neuroimaging: nationwide Medicare data for 1993 and 1998. AJNR Am J Neuroradiol 2001; 22: 1643–1649.Google ScholarPubMed
44.Hutubessy, RC, Hanvoravongchai, P, Edejer, TT, Asian MRI Study Group. Diffusion and utilization of magnetic resonance imaging in Asia. Int J Technol Assess Health Care 2002; 18(3): 690–704.Google Scholar
45.Oh, EH, Imanaka, Y, Evans, E. Determinants of the diffusion of computed tomography and magnetic resonance imaging. Int J Technol Assess Health Care 2005; 21(1): 73–80.CrossRefGoogle ScholarPubMed